CPT1A mediates chemoresistance in human hypopharyngeal squamous cell carcinoma via ATG16L1-dependent cellular autophagy
Open Access
- 11 October 2023
- journal article
- research article
- Published by Elsevier in Cell Insight
- Vol. 2 (6) , 100127
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32070770, 82172921)
- Science and Technology Commission of Shanghai Municipality (20ZR1456000)
This publication has 32 references indexed in Scilit:
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatmentCell Death & Disease, 2013
- Aberrant Expression of Beclin-1 and LC3 Correlates with Poor Prognosis of Human Hypopharyngeal Squamous Cell CarcinomaPLOS ONE, 2013
- Carnitine Palmitoyltransferase (CPT) Modulators: A Medicinal Chemistry Perspective on 35 Years of ResearchJournal of Medicinal Chemistry, 2011
- The Double-Edged Sword of Autophagy Modulation in CancerClinical Cancer Research, 2009
- The Atg16L Complex Specifies the Site of LC3 Lipidation for Membrane Biogenesis in AutophagyMolecular Biology of the Cell, 2008
- The Atg12-Atg5 Conjugate Has a Novel E3-like Activity for Protein Lipidation in AutophagyJournal of Biological Chemistry, 2007
- Chemoresistance in solid tumoursAnnals of Oncology, 2006
- Novel Effect of C75 on Carnitine Palmitoyltransferase I Activity and Palmitate OxidationBiochemistry, 2006
- Mechanisms of Drug Resistance in Cancer ChemotherapyMedical Principles and Practice, 2005
- Human Apg3p/Aut1p Homologue Is an Authentic E2 Enzyme for Multiple Substrates, GATE-16, GABARAP, and MAP-LC3, and Facilitates the Conjugation of hApg12p to hApg5pJournal of Biological Chemistry, 2002